STS-135 (drug)
STS-135 is a synthetic cannabinoid that is also a designer drug. It was first detected in smoking products in Japan in 2012. The drug is named after the Space Shuttle Atlantis's final mission, STS-135.
Chemistry[edit]
STS-135 is a derivative of Adamantane, a synthetic diamond. It is part of the naphthoylindole family, which also includes JWH-018 and AM-2201. These are all cannabinoid receptor agonists. STS-135 is a CB1 receptor agonist, which is the same receptor that THC, the main active ingredient in cannabis, binds to.
Effects[edit]
The effects of STS-135 are similar to those of other synthetic cannabinoids and include euphoria, relaxation, and altered perception. However, it also has a number of negative effects, including anxiety, paranoia, and psychosis. It is also associated with a number of health risks, including tachycardia, hypertension, and seizures.
Legal Status[edit]
STS-135 is illegal in many countries, including the United States, where it is classified as a Schedule I drug. It is also illegal in the United Kingdom, where it is classified as a Class B drug.
See Also[edit]
- Synthetic cannabinoids
- Designer drugs
- Adamantane
- Naphthoylindole
- Cannabinoid receptor
- CB1 receptor
- THC
- Cannabis
- Euphoria
- Relaxation
- Altered perception
- Anxiety
- Paranoia
- Psychosis
- Tachycardia
- Hypertension
- Seizures
- Schedule I drug
- Class B drug
 | This medical article is a stub. You can help WikiMD by expanding the page. |
-
5F-APICA.svg
